DCM
EXAS

Decade Capital Management’s Exact Sciences EXAS Stock Holding History

Decade Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-587,556
Closed -$8.17M – 251
2013
Q2 		$8.17M Buy
+587,556
New +$6.38M 0.52% 58

Other funds holding EXAS

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
JPCCM
J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Decade Capital Management's EXAS Position: Q3 2013 in Review

Decade Capital Management sold out of Exact Sciences (EXAS) in Q3 2013, closing a stake of 587,556 shares — an estimated $8.17M sold.

Decade Capital Management first reported a position in EXAS in Q2 2013 and held it in 1 quarter. The position peaked at $8.17M in Q2 2013. 129 funds tracked by Wall St. Rank hold EXAS as of Q3 2013.

  • Decade Capital Management reported no remaining Exact Sciences position as of Q3 2013 after selling out during the quarter.
  • Decade Capital Management sold 587,556 Exact Sciences shares in Q3 2013, an estimated $8.17M.
  • Decade Capital Management first reported a position in Exact Sciences in Q2 2013 and held it in 1 quarter.
  • Decade Capital Management's Exact Sciences position peaked at $8.17M in Q2 2013.
  • 129 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2013.

Based on Decade Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.